Thomas J. Schaefer

Thomas J. Schaefer discloses dealings in Arcadia Biosciences, Inc. to SEC (Form 4). The record holds 5 filings, for trades running from 1 February 2023 to 3 February 2025.

No open-market sale appears; the market trades are 5 purchases worth €6,695. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2025 to date brings 1 purchase and no sales.

Half of the purchases are above €1,337 and half below. Of 5 purchases, 2 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

Most recently, on 5 February 2025, the filings show an open-market purchase worth €1,701 in Arcadia Biosciences, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.